Dept of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, 641 Lexington Ave, 7th floor, New York, NY 10022, USA.
J Clin Oncol. 2010 Jan 10;28(2):348-56. doi: 10.1200/JCO.2009.23.0201. Epub 2009 Dec 7.
Geriatric issues in cancer are becoming prominent. Depression is a significant concern for both the elderly and patients with cancer, yet identifying depression in these patients is difficult and often leads to under-recognition. We conducted a systematic review to determine which depression instruments are appropriate for use in geriatric patients with cancer.
We identified the most commonly used self-report depression instruments. We then used the criteria established in the US Food and Drug Administration Draft Guidance on Patient-Reported Outcome Measures to determine the extent of validation evidence of these measures in geriatric cancer populations. Finally, we determined which instruments captured depressive symptoms that are common among elderly patients with cancer.
Eight measures were selected as the most commonly used instruments. These were the Beck Depression Inventory-II, Brief Symptom Inventory-18, Center for Epidemiologic Studies-Depression Scale, Geriatric Depression Scale-15, Hospital Anxiety and Depression Scale, Patient Health Questionnaire-9, Profile of Mood States-Short Form, and Zung Self-Rating Depression Scale. Many have been validated for use with geriatric adults and patients with cancer; however, data addressing content validity and responder definition were lacking. To date, there is no validation information for geriatric patients with cancer. Furthermore, symptom profile analysis revealed that these measures do not identify many symptoms signaling depression in geriatric patients with cancer.
The validation evidence for use of common depression instruments in geriatric patients with cancer is lacking. This, and the possibility that these measures may not assess common depressive symptoms in geriatric patients with cancer, questions the adequacy of these scales in this population.
癌症患者的老年问题日益突出。抑郁是老年人和癌症患者都非常关注的问题,但识别这些患者的抑郁情绪很困难,往往导致识别不足。我们进行了一项系统评价,以确定哪些抑郁量表适合用于患有癌症的老年患者。
我们确定了最常用的自评抑郁量表。然后,我们使用美国食品和药物管理局(FDA)患者报告结局测量指南草案中确立的标准,确定这些措施在老年癌症人群中的验证证据的程度。最后,我们确定了哪些工具可以捕捉到老年癌症患者中常见的抑郁症状。
选择了 8 种措施作为最常用的工具。这些是贝克抑郁量表第二版、简明症状量表 18 项、流行病学研究中心抑郁量表、老年抑郁量表 15 项、医院焦虑和抑郁量表、患者健康问卷 9 项、情绪状态简表和zung 自评抑郁量表。其中许多已经过验证,可用于老年成年人和癌症患者;然而,缺乏关于内容有效性和应答者定义的数据。迄今为止,尚无针对老年癌症患者的验证信息。此外,症状特征分析表明,这些措施并不能识别出许多在老年癌症患者中提示抑郁的症状。
在老年癌症患者中使用常见抑郁量表的验证证据不足。这一点,以及这些措施可能无法评估老年癌症患者中常见的抑郁症状,使得这些量表在该人群中的适用性受到质疑。